The VEGF-C ELISA assay revealed that PC-3 cells themselves secreted VEGF-C and potentially activated VEGF-C/VEGFR-3 signaling through an autocrine mechanism, leading to autonomous tumor development in prostate cancer. Here, FLT4 is linked to prostate carcinoma.